Neuroimaging as a selection tool and endpoint in preclinical and clinical trials

Muir, K. W. and Macrae, I. M. (2016) Neuroimaging as a selection tool and endpoint in preclinical and clinical trials. Translational Stroke Research, 7(5), pp. 368-377. (doi: 10.1007/s12975-016-0487-1) (PMID:27543177)

121357.pdf - Published Version
Available under License Creative Commons Attribution.



Standard imaging in acute stroke enables the exclusion of non-stroke structural CNS lesions and cerebral haemorrhage from clinical and pre-clinical ischaemic stroke trials. In this review, the potential benefit of imaging (e.g., angiography and penumbral imaging) as a translational tool for trial recruitment and the use of imaging endpoints are discussed for both clinical and pre-clinical stroke research. The addition of advanced imaging to identify a “responder” population leads to reduced sample size for any given effect size in phase 2 trials and is a potentially cost-efficient means of testing interventions. In pre-clinical studies, technical failures (failed or incomplete vessel occlusion, cerebral haemorrhage) can be excluded early and continuous multimodal imaging of the animal from stroke onset is feasible. Pre- and post-intervention repeat scans provide real time assessment of the intervention over the first 4–6 h. Negative aspects of advanced imaging in animal studies include increased time under general anaesthesia, and, as in clinical studies, a delay in starting the intervention. In clinical phase 3 trial designs, the negative aspects of advanced imaging in patient selection include higher exclusion rates, slower recruitment, overestimated effect size and longer acquisition times. Imaging may identify biological effects with smaller sample size and at earlier time points, compared to standard clinical assessments, and can be adjusted for baseline parameters. Mechanistic insights can be obtained. Pre-clinically, multimodal imaging can non-invasively generate data on a range of parameters, allowing the animal to be recovered for subsequent behavioural testing and/or the brain taken for further molecular or histological analysis.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Macrae, Professor Mhairi and Muir, Professor Keith
Authors: Muir, K. W., and Macrae, I. M.
College/School:College of Medical Veterinary and Life Sciences > School of Psychology & Neuroscience
Journal Name:Translational Stroke Research
ISSN (Online):1868-601X
Published Online:20 August 2016
Copyright Holders:Copyright © 2016 The Authors
First Published:First published in Translational Stroke Research 7(5): 368-377
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record